Ten-year experience in atenolol use and exercise evaluation in children with genetically proven long QT syndrome

Conclusions Atenolol is an effective treatment for genetically proven LQT1 and LQT2 children and adolescents, with good tolerability. In LQT1 patients, QTc intervals at 2–3min into the recovery phase of exercise were significantly prolonged, particularly in patients with transmembrane mutations.
Source: Journal of Arrhythmia - Category: Cardiology Source Type: research